BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19449377)

  • 1. Molecular characterization of the response to chemotherapy in conventional osteosarcomas: predictive value of HSD17B10 and IFITM2.
    Salas S; Jézéquel P; Campion L; Deville JL; Chibon F; Bartoli C; Gentet JC; Charbonnel C; Gouraud W; Voutsinos-Porche B; Brouchet A; Duffaud F; Figarella-Branger D; Bouvier C
    Int J Cancer; 2009 Aug; 125(4):851-60. PubMed ID: 19449377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An expression signature classifies chemotherapy-resistant pediatric osteosarcoma.
    Mintz MB; Sowers R; Brown KM; Hilmer SC; Mazza B; Huvos AG; Meyers PA; Lafleur B; McDonough WS; Henry MM; Ramsey KE; Antonescu CR; Chen W; Healey JH; Daluski A; Berens ME; Macdonald TJ; Gorlick R; Stephan DA
    Cancer Res; 2005 Mar; 65(5):1748-54. PubMed ID: 15753370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profiles of osteosarcoma that can predict response to chemotherapy.
    Man TK; Chintagumpala M; Visvanathan J; Shen J; Perlaky L; Hicks J; Johnson M; Davino N; Murray J; Helman L; Meyer W; Triche T; Wong KK; Lau CC
    Cancer Res; 2005 Sep; 65(18):8142-50. PubMed ID: 16166288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
    Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
    BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between ERK1 and STAT3 expression and chemoresistance in patients with conventional osteosarcoma.
    Salas S; Jiguet-Jiglaire C; Campion L; Bartoli C; Frassineti F; Deville JL; Maues De Paula A; Forest F; Jézéquel P; Gentet JC; Bouvier C
    BMC Cancer; 2014 Aug; 14():606. PubMed ID: 25146150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma.
    Baumhoer D; Smida J; Specht K; Bink K; Quintanilla-Martinez L; Rosemann M; Siggelkow H; Nathrath WB; Atkinson MJ; Bielack S; Jundt G; Nathrath M
    Hum Pathol; 2011 Jun; 42(6):859-66. PubMed ID: 21292304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p16 expression predicts neoadjuvant tumor necrosis in osteosarcomas: reappraisal with a larger series using whole sections.
    Kosemehmetoglu K; Ardic F; Karslioglu Y; Kandemir O; Ozcan A
    Hum Pathol; 2016 Apr; 50():170-5. PubMed ID: 26997452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization.
    Kresse SH; Ohnstad HO; Paulsen EB; Bjerkehagen B; Szuhai K; Serra M; Schaefer KL; Myklebost O; Meza-Zepeda LA
    Genes Chromosomes Cancer; 2009 Aug; 48(8):679-93. PubMed ID: 19441093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-α/β receptor as a prognostic marker in osteosarcoma.
    Kubo T; Shimose S; Matsuo T; Fujimori J; Arihiro K; Ochi M
    J Bone Joint Surg Am; 2011 Mar; 93(6):519-26. PubMed ID: 21411701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribosomal protein S3 regulates GLI2-mediated osteosarcoma invasion.
    Nagao-Kitamoto H; Setoguchi T; Kitamoto S; Nakamura S; Tsuru A; Nagata M; Nagano S; Ishidou Y; Yokouchi M; Kitajima S; Yoshioka T; Maeda S; Yonezawa S; Komiya S
    Cancer Lett; 2015 Jan; 356(2 Pt B):855-61. PubMed ID: 25449781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas.
    Salas S; Bartoli C; Deville JL; Gaudart J; Fina F; Calisti A; Bollini G; Curvale G; Gentet JC; Duffaud F; Figarella-Branger D; Bouvier C
    Virchows Arch; 2007 Dec; 451(6):999-1007. PubMed ID: 17786474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.
    Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z
    Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P16 expression predicts necrotic response among patients with osteosarcoma receiving neoadjuvant chemotherapy.
    Borys D; Canter RJ; Hoch B; Martinez SR; Tamurian RM; Murphy B; Bishop JW; Horvai A
    Hum Pathol; 2012 Nov; 43(11):1948-54. PubMed ID: 22578565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and prognostic relevance of centromere protein A in primary osteosarcoma.
    Gu XM; Fu J; Feng XJ; Huang X; Wang SM; Chen XF; Zhu MH; Zhang SH
    Pathol Res Pract; 2014 Apr; 210(4):228-33. PubMed ID: 24440098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Livin and Bcl-2 expression in high-grade osteosarcoma.
    Nedelcu T; Kubista B; Koller A; Sulzbacher I; Mosberger I; Arrich F; Trieb K; Kotz R; Toma CD
    J Cancer Res Clin Oncol; 2008 Feb; 134(2):237-44. PubMed ID: 17632732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
    Wang Z; Cai H; Lin L; Tang M; Cai H
    Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of hypoxia-inducible factor 1α in osteosarcoma and its value in predicting chemosensitivity].
    Chen Y; Wang CM; Shi YQ; Yang Y
    Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):899-904. PubMed ID: 23336375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics study of open biopsy samples identifies peroxiredoxin 2 as a predictive biomarker of response to induction chemotherapy in osteosarcoma.
    Kubota D; Mukaihara K; Yoshida A; Tsuda H; Kawai A; Kondo T
    J Proteomics; 2013 Oct; 91():393-404. PubMed ID: 23911960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma.
    Korpi JT; Hagström J; Lehtonen N; Parkkinen J; Sorsa T; Salo T; Laitinen M
    Surg Oncol; 2011 Mar; 20(1):e18-22. PubMed ID: 20880700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The β5/focal adhesion kinase/glycogen synthase kinase 3β integrin pathway in high-grade osteosarcoma: a protein expression profile predictive of response to neoadjuvant chemotherapy.
    Le Guellec S; Moyal EC; Filleron T; Delisle MB; Chevreau C; Rubie H; Castex MP; de Gauzy JS; Bonnevialle P; Gomez-Brouchet A
    Hum Pathol; 2013 Oct; 44(10):2149-58. PubMed ID: 23845472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.